Our mission is to give hope to patients with serious and difficult-to-treat diseases. Ipsen Canada currently offers therapies to Canadians in the areas of oncology, neuroscience and rare diseases.
Ipsen’s commitment to oncology is demonstrated by its growing portfolio of therapies aimed at helping patients with neuroendocrine tumors.
Ipsen continues to develop innovative medicines in rare diseases to address conditions with unmet needs, with specific investment in pituitary pathologies and growth disorders.
Our focus on movement disorders includes improving the mobility, autonomy and quality of life of patients with these very disabling motor disorders. Our involvement in developing neurotoxins dates back over two decades.